Clinical Trials
4 trialsNCT03430011 2024-05-24
EVOLVE
Juno Therapeutics, a Subsidiary of Celgene
Phase 1/2 Completed
NCT04227275 2023-08-21
A Study of CART-PSMA-TGFβRDN in Patients With Metastatic Castration Resistant Prostate Cancer
Tceleron Therapeutics, Inc.
Phase 1 Terminated
NCT02326376 2020-01-18
Kineret CAPS Post Authorisation Study
Swedish Orphan Biovitrum
Completed
NCT00537667 2009-11-26
The SPECTRA Study
Swedish Orphan Biovitrum
Phase 2 Terminated